icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
Washington on 04-08
November 2022
Back grey_arrow_rt.gif
 
 
 
Use of Psychiatric Medication and Drug-Drug Interactions in Patients with HCV Infection Treated with Pangenotypic Direct-Acting Antivirals
 
 
  AASLD 2022 Nov 4-8
 
Juan Turnes1, Antonio García-Herola2, Ramón Morillo-Verdugo3, Marinela Méndez4, Cristina de Alvaro4, Cándido Hernández5, Antoni Sicras-Mainar6 1Gastroenterology and Hepatology Department, CHU. Pontevedra, Spain; 2Digestive Medicine Department. Hospital Marina Baixa de Villajoyosa (Alicante), Spain; 3Hospital Pharmacy, Hospital de Valme, AGS Sur de Sevilla, Spain; 4Medical Affairs, Gilead Sciences S.L., Madrid, Spain; 5Global Medical Affairs, Gilead Sciences Europe Ltd, U.K; 6Health Economics and Outcomes Research, Atrys Health, Barcelona, Spain

1114221

1114222

1114223

1114224

1114225

1114226